Skip to content

Evaluation of postnatal regional ventilation distribution in the initial care of newborns with congenital lung malformations (ReVent NeoLung)

Evaluation of postnatal regional ventilation distribution in the initial care of newborns with congenital lung malformations (ReVent NeoLung) - ReVent NeoLung

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00039725
Enrollment
40
Registered
2026-03-26
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q79.0 Q33.0 Q33.2 Q33.6 J94.0

Interventions

Group 1: All newborns (preterm infants, term infants >24 weeks’ gestation) with a congenital lung malformation (mandatory: prenatal diagnosis). Description of the study protocol: Immediately after spo

Sponsors

Uniklinik Bonn, Klinik für Neonatologie und Pädiatrische Intensivmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All newborns (preterm infants and term newborns >24 weeks of gestation) with a congenital lung malformation (mandatory: prenatal diagnosis)

Exclusion criteria

Exclusion criteria: 1) Patients receiving palliative care 2) Lack of parental consent (prior to birth) 3) Contraindication to performing EIT measurement according to approval (e.g., presence of a pacemaker) or inability to perform EIT measurement on the thorax due to wound dressings or indwelling drains.

Design outcomes

Primary

MeasureTime frame
Detection of >90% of spontaneous and mechanical breaths in the first 60 minutes after birth using EIT.

Secondary

MeasureTime frame
1) Detection of regional differences in ventilation distribution (affected/ipsilateral vs. healthy/contralateral lung side). 2) Detection of areas of inhomogeneous ventilation distribution on the affected (ipsilateral) lung side.

Countries

Germany

Contacts

Public ContactLukas Schröder

Uniklinik Bonn, Klinik für Neonatologie und Pädiatrische Intensivmedizin

lukas.schroeder@ukbonn.de+49 228 287 37834

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026